Status:
COMPLETED
Awareness and Attitudes Regarding Prenatal and Preimplantation Genetic Diagnosis for Inherited Breast/Ovarian Cancer Risk
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Collaborating Sponsors:
The New School for Social Research
Hadassah Medical Organization
Conditions:
Breast Cancer
Ovarian Cancer
Eligibility:
All Genders
18-39 years
Brief Summary
We are inviting you to participate in a study of how people who have had genetic counseling for breast/ovarian cancer risk feel about certain reproductive technologies, preimplantation genetic diagnos...
Eligibility Criteria
Inclusion
- Females and males who are carriers of deleterious mutations in the genes BRCA1 or BRCA2.
- Over age 18 and:
- For women, less than 43
- For men, less than 50.
- Received genetic testing and counseling for BRCA.
- Fluent in English.
Exclusion
- Patients who are currently under treatment (chemotherapy, radiation)
- Individuals who refuse to discuss reproductive issues.
- Unable to give informed consent due to physical, cognitive, or psychiatric disability
Key Trial Info
Start Date :
March 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT00735150
Start Date
March 1 2008
End Date
October 1 2010
Last Update
October 11 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan-Kettering Cancer Center
New York, New York, United States, 10065